Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Integrated Device Combines Techniques to Detect Malaria

By LabMedica International staff writers
Posted on 08 Dec 2015
Recombinase polymerase amplification (RPA) is promising for further development since it operates in a short time frame and produces a product that can be visually detected on a lateral flow dipstick.

Isothermal amplification techniques are emerging as a promising method for malaria diagnosis since they are capable of detecting extremely low concentrations of parasite target while mitigating the need for infrastructure and training required by other nucleic acid based tests. More...


Bioengineers at Rice University (Houston, TX, USA) developed an integrated device capable of carrying out isothermal amplification using the RPA reaction, post-amplification dilution, and lateral flow detection of the resulting product. The paper and plastic device developed amplified the target using RPA; diluted the resulting product; and detected the product using a lateral flow sandwich assay. In addition, the device transferred the product between the amplification, dilution, and detection modules. A sequence of paper pads loaded with various reagents was used to carry out these functions.

The device is made of simple components, can be assembled by the user and uses a novel slider method to transport reagents through the system. The equipment needed beyond the device itself and the sample to be tested are a hot plate capable of 37 °C, a reusable 25 gram metal weight, the RPA master mix, the running/dilution buffer and pipettes to load these reagents onto the device dilution, running buffer, RPA and sample pads. This device runs the entire assay, including detection, in around an hour and has a limit of detection equivalent to when the assay is run using conventional methods on the bench top. The total run time for the device is 55 minutes, and including the loading and operation of the device, the entire assay can be carried out in about an hour.

The authors concluded that the fabricated device amplified a sequence which is common to the human infectious species of Plasmodium and operated an isothermal amplification reaction which is rapid and has an easy visual readout. A paper and plastic device was also developed which carries out the amplification of the samples, dilutes the product and runs the result on a lateral flow strip. When tested on synthetic targets, a limit of detection of 5 copies/µL (50 total copies) was found, which matches the performance of the same assay run on the bench top. The study was published on November 26, 2015, in the Malaria Journal.

Related Links:

Rice University 



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.